A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

Clinical trial NCT07641634 · RECRUITING

Trial details

NCT number: NCT07641634
Sponsor: Prolium Bioscience, Inc
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Systemic Sclerosis (SSc)Scleroderma, Systemic Scleroderma

Start date: 2025-10-27
Primary completion: 2027-01-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.